About the Journal
About the Journal of Clinical Pathways
- Peer-reviewed journal
- Available in print & online
- Six issues per year
- ISSN: 2380-9604; eISSN: 2380-9612
- Address: 70 East Swedesford Road, Suite 100
Malvern, PA 19355
Editorial Scope and Mission
Journal of Clinical Pathways® (JCP) is the only peer-reviewed publication solely dedicated to the in-depth exploration of oncology clinical pathways—a critical area of cancer care that is not covered with comparable rigor or focus in any other journal. What truly sets JCP apart is its multidisciplinary editorial board, which brings together health care providers, researchers, payers, and clinical pathways experts. This diverse representation ensures that every piece published reflects the perspectives and needs of all key stakeholders involved in the delivery of value-based cancer care.
JCP serves as a vital forum for educational and scholarly articles on the development, implementation, and evaluation of oncology clinical pathways. It covers a wide array of relevant and emerging topics, including:
- Comparative-effectiveness research
- Big data analytics
- Methodologies in pathway development
- Implementation science and adherence strategies
- Health economics and outcomes research
- Patient-centered outcomes
- Alternative payment and value-based care models
JCP's mission is to drive forward the conversation around oncology clinical pathways as a transformative tool for delivering high-quality, cost-effective care—especially as the health care system transitions from fee-for-service to value-based models. Clinical pathways unite real-world data with clinical decision-making to promote precision, consistency, and optimal outcomes in cancer care.
In every issue, JCP investigates how pathways can help address some of the most pressing challenges in oncology: controlling rising costs, minimizing patient risk, reducing unwarranted care variation, and improving outcomes. More than just a journal, JCP functions as a collaborative platform for stakeholders across the spectrum—oncologists, payers, researchers, and health care leaders—to share insights, report on real-world applications, and showcase the impact of pathway-driven approaches within their institutions.
Unlike broader publications that touch on health economics or clinical research tangentially, JCP maintains a laser focus on clinical pathways in oncology. This singular commitment, supported by a uniquely qualified editorial board, makes JCP the definitive resource for advancing clinical pathways as a cornerstone of value-based cancer care.
About the Editor
The founding Editor-in-Chief of Journal of Clinical Pathways, Winston Wong, PharmD, is president of W-Squared Group, a consultancy that supports small healthcare innovators in developing their value statements before launching their technology in the government or commercial marketplace. Dr Wong was previously the Associate Vice President of Pharmacy Management with CareFirst BlueCross BlueShield, where he received numerous accolades for the implementation of his pharmacist-driven Medication Therapy Management (MTM) program that expanded to include the entire prescription benefit commercial population in late 2011. Dr Wong was awarded the APhA-APPM Pharmacy Practice Merit Award and the Honorary President’s Award in 2009 to recognize his efforts to promote medication therapy management in the commercial sector.
About the Publisher
HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit hmpglobal.com.
